Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
468.00
+8.71 (1.90%)
Aug 13, 2025, 4:00 PM - Market closed
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $13.15 billion as of August 13, 2025. Its market cap has increased by 10.10% in one year.
Market Cap
13.15B
Enterprise Value
13.25B
1-Year Change
10.10%
Ranking
Category
Stock Price
$468.00
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $13.15B, an increase of 1,093.39%. That is a compound annual growth rate of 31.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 13.15B | 27.32% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.09B |
| Johnson & Johnson | 418.88B |
| AbbVie | 355.10B |
| UnitedHealth Group | 244.76B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.71B |
| Novo Nordisk | 223.00B |